Brief: Elos Medtech: effects of final acquisition analysis relating to Onyx Medical

Elos Medtech AB

29/01/2016 07:01

Jan 29 (Reuters) - Elos Medtech AB  ELOSSb.ST : 
    * Says acquired the North American company Onyx Medical LLC in April 2015 
    * Effect is increase of about 0.8 million Swedish crowns  ($95,000) in amortisation cost for 
previously reported quarters in 2015  
    * Nonrecurring cost of about 3 million crowns has arisen for changes in inventory 
    * Nonreccuring cost implies total earnings impact on previously reported quarters of about 
1.9 million crowns each for Q2 and Q3 
    * Revision of the contingent consideration result in an increase of some 40 million crowns 
to a maximum amount of about 116 million crowns  
 
Source text for Eikon:  ID:nWkraB4419  
     
Further company coverage:  ELOSSb.ST  
 
($1 = 8.5138 Swedish crowns) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))